Legacy Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Legacy Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$536K	Hold	980	–	–	0.18%	99
2021 Q4	$645K	Hold	980	–	–	0.21%	93
2021 Q3	$609K	Hold	980	–	–	0.22%	93
2021 Q2	$619K	Hold	980	–	–	0.22%	90
2021 Q1	$480K	Hold	980	–	–	0.18%	97
2020 Q4	$490K	Hold	980	–	–	0.19%	94
2020 Q3	$385K	Hold	980	–	–	0.16%	102
2020 Q2	$324K	Hold	980	–	–	0.14%	108
2020 Q1	$237K	Hold	980	–	–	0.12%	115
2019 Q4	$256K	Hold	980	–	–	0.1%	132
2019 Q3	$266K	Hold	980	–	–	0.12%	128
2019 Q2	$270K	Hold	980	–	–	0.12%	120
2019 Q1	$219K	Buy	+980	New	+$202K	0.1%	128
2018 Q4	–	Sell	-980	Closed	-$245K	–	130
2018 Q3	$245K	Hold	980	–	–	0.11%	119
2018 Q2	$214K	Buy	+980	New	+$202K	0.1%	121

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Legacy Capital Partners's IDXX Position: Q1 2022 in Review

Legacy Capital Partners held its Idexx Laboratories (IDXX) position steady in Q1 2022 at 980 shares worth $536K. The position accounts for 0.18% of the portfolio, ranked #99.

Legacy Capital Partners first reported a position in IDXX in Q2 2018 and has held it in 15 quarters since. The position peaked at $645K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Legacy Capital Partners held 980 shares of Idexx Laboratories worth $536K as of Q1 2022.
Legacy Capital Partners left its Idexx Laboratories share count unchanged in Q1 2022.
Idexx Laboratories made up 0.18% of Legacy Capital Partners's portfolio in Q1 2022, its #99 holding.
Legacy Capital Partners first reported a position in Idexx Laboratories in Q2 2018 and has held it in 15 quarters since.
Legacy Capital Partners's Idexx Laboratories position peaked at $645K in Q4 2021.
1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.